Federal Register · Regulatory notice
Certain Clear Aligners and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting In Part a Motion To Amend the Complaint and Notice of Investigation
Notice is hereby given that the U.S. International Trade Commission has determined not to review the presiding chief administrative law judge's ("CALJ") initial determination ("ID") (Order No. 11) granting a motion to amend the complaint and notice of investigation ("NOI") to (1) add allegations of infringement of claim 24 for U.S. Patent No. 11,766,313 ("the `313 patent"); (2) add allegations of infringement of claim 28 for U.S. Patent No. 11,766,314 ("the `314 patent"); (3) add allegations of infringement of claims 2 and 14 for U.S. Patent No. 8,866,977 ("the `977 patent"); and (4) add allegations of infringement of claim 9 for U.S. Patent No. 10,980,616 ("the `616 patent").
Follow ALGN- Became public
- Jun 8, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 7:46 PM EST
Why this is connected
The source explicitly mentions ALIGN TECHNOLOGY INC. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
s://edis.usitc.gov . For help accessing EDIS, please email [email protected] . General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov . Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission's TDD terminal, telephone (202) 205-1810. SUPPLEMENTARY INFORMATION: On December 29, 2025, the Commission instituted this investigation based on a complaint filed by Align Technology, Inc. of Tempe, Arizona (``Align''). 90 FR 245 (Dec. 29, 2025). The complaint alleged violations of section 337 of the Tariff Act of 1930, as amended, based on the importation into the United States, the sale for importation, or the sale within the United States after importation of certain clear aligners and components thereof by reason of infringement of one or more of claims 1 and 16 of the `313 patent; claims 1, 11, and 21 of the `314 patent; claims 1 and 9 of the `977 patent; claim 1 of U.S. Patent No. 12,059,321; claims 1, 12, and 20 of the `616 patent; and claims 1, 17, and 21 of U.S. Patent No. 11,490,996 (``the `996 patent''). Id. The Commission's notice of investigation named the following respondents: Angelalign Technology Inc. of Shanghai, China; Wuxi EA Medical Instruments of Jiangsu, China; Wuxi EA Bio-Tech Co., Ltd. of Jiangsu, China; Shanghai EA Medical Instruments Co.
Congressional trading in ALGN
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 11, 2025 · disclosed Oct 22, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Aug 4, 2025 · disclosed Sep 12, 2025 · Spouse
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Mar 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Feb 26, 2025 · disclosed Mar 6, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.